Overview

Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment

Status:
Terminated
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The study objective is to evaluate the relative merits, safety and effectiveness of Transoral Incisionless Fundoplication (TIF) in GERD patients currently treated with daily Proton Pump Inhibitors (PPIs).
Phase:
Phase 3
Details
Lead Sponsor:
University of Pittsburgh
Collaborators:
Crospon
EndoGastric Solutions
Sandhill Scientific
Treatments:
Esomeprazole
Omeprazole
Pantoprazole
Proton Pump Inhibitors
Rabeprazole